ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

Prateek Bhatia discusses optimizing infusion operations through technology, data analytics, and patient journey understanding at the ASHP Midyear Meeting.

Pharmacy leaders at ASHP Midyear 2025 highlight urgent concerns about future uncertainties and preparedness for crises impacting health systems and patient care.

Diana Isaacs, PharmD, highlights evolving criteria for insulin pump therapy in type 2 diabetes.

Ginger Thorpe discusses how in-house specialty pharmacy models enhance patient care, streamline communication, and boost health system revenue amid rising demand.

Allegheny General Hospital enhances pharmacy operations through centralized, robotics-enabled IV compounding, boosting efficiency and patient care.

Prescriber incentives boost nicotine replacement therapy prescribing and enhance patient access to smoking cessation support in health care settings.

Pharmacists debate the effectiveness and ethics of GLP-1 agonists for pediatric obesity, highlighting the need for balanced treatment approaches.

Pharmacy leaders navigate complex compliance challenges, budget constraints, and evolving technology to enhance safety and efficiency in compounding practices.

IV compounding robotics enhance safety, reduce drug shortages, and improve efficiency in hospital pharmacies, driving a shift towards automation.

Pharmacists explore AI's transformative potential, evaluating its applications and ensuring ethical integration to enhance patient care and pharmacy operations.

Pharmacists leverage sodium-glucose cotransporter 2 (SGLT2) inhibitors to improve interconnected cardiovascular-kidney-metabolic (CKM) syndrome outcomes through holistic, patient-centered care.

Economic factors are driving sterile injectable drug shortages, but collaborative strategies can enhance health care industry resiliency.

Pharmacists can enhance patient care through integrated treatment strategies.

Specialty pharmacy services are helping improve IBD care by supporting patient education, access, and confidence in biosimilars

Pharmacists play a vital role in preventing maternal and neonatal mortality by understanding pregnancy-specific medication needs and emergency care strategies.

Rural hospitals face a crisis, but pharmacists can expand services to alleviate the uninsured patient burden and enhance community health.

Pharmacist-led refill authorizations enhance outpatient care, reduce physician burnout, and streamline pharmacy management in health systems, improving patient satisfaction.

Emerging pharmacy trends will be highlighted at the American Society of Health-System Pharmacists (ASHP) Midyear 2025, including AI innovations, GLP-1 therapies, and evolving geriatric and neonatal care.

Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, discusses the pharmacists role in diabetes care.

Pharmacy Times interviews Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, about glucagon-like peptide-1 receptors for diabetes treatment.

New medications like glucagon-like peptide-1 agonists and resmetirom show promise in reversing fatty liver disease and preventing progression.

Pharmacists can educate patients on controlling risk factors and stay up-to-date on emerging therapies like SGLT2 inhibitors and finerenone that can slow disease progression.

Lp(a) is a critical risk factor for atherosclerotic cardiovascular disease, but current lipid-lowering therapies are largely ineffective at lowering Lp(a) levels.

Administering first-dose antibiotics to septic shock patients via IV push rather than continuous infusion could improve the speed of antibiotic delivery and reduce logistical challenges.

The disparity highlights opportunities for pharmacists to get involved and address health disparities.

Pharmacists are crucial in educating patients, identifying eligible individuals, and promoting uptake of the newly expanded RSV vaccination recommendations for older adults.

Adoption barriers include insurance coverage, patient and provider education, and regulatory hurdles that require aligned initiatives across stakeholders.

Pharmacists are encouraged to work closely with health care providers to ensure appropriate use of high-cost Intravenous immunoglobulin (IVIG) therapy for BK nephropathy.

The 2025 GOLD Report emphasizes the importance of tailoring combination treatments based on patient factors like eosinophil counts and exacerbation history.